Studies have found that interfering with SLC3A2 can inhibit the M2 polarization of BLCA tumor-associated macrophages, thereby inhibiting BLCA cell proliferation, invasion, and migration (Wu P. et al., 2024). The gene discussed is SLC3A2; the disease is bladder transitional cell carcinoma.